Investment in Britain’s vital life sciences sector is under threat due to a deteriorating commercial environment. Senior executives from major pharmaceutical companies, including Johnson & Johnson, are voicing concerns that
Investment in Britain’s vital life sciences sector is under threat due to a deteriorating commercial environment. Senior executives from major pharmaceutical companies, including Johnson & Johnson, are voicing concerns that






